Crystal Structure Determination and Molecular Docking Studies of 4- (5-Phenyl Pyrazin-2-Yl)-4h-1,2,4 Triazole-3-Thiol with Focal Adhesion Kinase Inhibitors

Fig. (4) The pharmacophore of the protein interacting with the ligand; residues forming hydrogen bonding.